The normal function of BCMA binding on myeloma cells is to trigger downstream signaling intracellularly via the B-cell activating factor (BAFF) pathway, thus promoting plasma cell survival and proliferation [9]. The gene discussed is TNFRSF17; the disease is plasma cell myeloma.